nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR2B—hypertension	0.154	0.395	CbGaD
Methysergide—HTR7—hypertension	0.0955	0.245	CbGaD
Methysergide—HTR1B—hypertension	0.0925	0.237	CbGaD
Methysergide—HTR1B—Pindolol—hypertension	0.0496	0.179	CbGbCtD
Methysergide—HTR2A—hypertension	0.048	0.123	CbGaD
Methysergide—HTR1B—Penbutolol—hypertension	0.0404	0.146	CbGbCtD
Methysergide—HTR1A—Nebivolol—hypertension	0.0365	0.132	CbGbCtD
Methysergide—HTR1D—Prazosin—hypertension	0.0333	0.12	CbGbCtD
Methysergide—HTR1A—Pindolol—hypertension	0.0311	0.112	CbGbCtD
Methysergide—HTR1B—Propranolol—hypertension	0.0254	0.0915	CbGbCtD
Methysergide—HTR1A—Penbutolol—hypertension	0.0253	0.0913	CbGbCtD
Methysergide—HTR1A—Prazosin—hypertension	0.02	0.0721	CbGbCtD
Methysergide—HTR1A—Propranolol—hypertension	0.0159	0.0573	CbGbCtD
Methysergide—HTR7—umbilical artery—hypertension	0.00508	0.0924	CbGeAlD
Methysergide—HTR7—vas deferens—hypertension	0.0041	0.0745	CbGeAlD
Methysergide—HTR7—superior cervical ganglion—hypertension	0.00341	0.062	CbGeAlD
Methysergide—HTR7—locus ceruleus—hypertension	0.00235	0.0428	CbGeAlD
Methysergide—HTR7—pulmonary artery—hypertension	0.00191	0.0348	CbGeAlD
Methysergide—HTR7—sympathetic nervous system—hypertension	0.00186	0.0338	CbGeAlD
Methysergide—HTR2A—arteriole—hypertension	0.00182	0.0331	CbGeAlD
Methysergide—HTR7—vagus nerve—hypertension	0.0018	0.0328	CbGeAlD
Methysergide—HTR7—vein—hypertension	0.00174	0.0317	CbGeAlD
Methysergide—HTR2A—locus ceruleus—hypertension	0.00147	0.0267	CbGeAlD
Methysergide—HTR7—autonomic nervous system—hypertension	0.00125	0.0227	CbGeAlD
Methysergide—HTR2A—pulmonary artery—hypertension	0.00119	0.0217	CbGeAlD
Methysergide—HTR2A—sympathetic nervous system—hypertension	0.00116	0.0211	CbGeAlD
Methysergide—HTR2A—vagus nerve—hypertension	0.00112	0.0204	CbGeAlD
Methysergide—HTR2A—vein—hypertension	0.00109	0.0197	CbGeAlD
Methysergide—HTR1B—artery—hypertension	0.00092	0.0167	CbGeAlD
Methysergide—HTR1D—artery—hypertension	0.00089	0.0162	CbGeAlD
Methysergide—HTR1E—brainstem—hypertension	0.000828	0.0151	CbGeAlD
Methysergide—HTR2A—autonomic nervous system—hypertension	0.00078	0.0142	CbGeAlD
Methysergide—HTR2A—hindlimb—hypertension	0.000721	0.0131	CbGeAlD
Methysergide—HTR1B—blood vessel—hypertension	0.000716	0.013	CbGeAlD
Methysergide—HTR7—artery—hypertension	0.000709	0.0129	CbGeAlD
Methysergide—Nicergoline—ADRA1A—hypertension	0.000702	0.158	CrCbGaD
Methysergide—HTR1D—blood vessel—hypertension	0.000694	0.0126	CbGeAlD
Methysergide—HTR2A—urine—hypertension	0.000636	0.0116	CbGeAlD
Methysergide—HTR7—endothelium—hypertension	0.000599	0.0109	CbGeAlD
Methysergide—HTR7—blood vessel—hypertension	0.000552	0.01	CbGeAlD
Methysergide—HTR1F—central nervous system—hypertension	0.000482	0.00876	CbGeAlD
Methysergide—SIGMAR1—cardiac ventricle—hypertension	0.000466	0.00846	CbGeAlD
Methysergide—HTR2A—artery—hypertension	0.000442	0.00804	CbGeAlD
Methysergide—SIGMAR1—myocardium—hypertension	0.000438	0.00796	CbGeAlD
Methysergide—HTR1E—central nervous system—hypertension	0.000418	0.00759	CbGeAlD
Methysergide—HTR1B—brainstem—hypertension	0.000392	0.00712	CbGeAlD
Methysergide—HTR1D—brainstem—hypertension	0.000379	0.00689	CbGeAlD
Methysergide—HTR2C—brainstem—hypertension	0.000375	0.00682	CbGeAlD
Methysergide—HTR2A—endothelium—hypertension	0.000374	0.00679	CbGeAlD
Methysergide—HTR2A—blood vessel—hypertension	0.000345	0.00626	CbGeAlD
Methysergide—HTR6—central nervous system—hypertension	0.000328	0.00596	CbGeAlD
Methysergide—SIGMAR1—nephron tubule—hypertension	0.000321	0.00584	CbGeAlD
Methysergide—HTR1B—cardiovascular system—hypertension	0.00032	0.00581	CbGeAlD
Methysergide—SIGMAR1—adrenal cortex—hypertension	0.000316	0.00575	CbGeAlD
Methysergide—HTR1A—brainstem—hypertension	0.000316	0.00574	CbGeAlD
Methysergide—HTR2B—adrenal cortex—hypertension	0.000315	0.00573	CbGeAlD
Methysergide—HTR1D—cardiovascular system—hypertension	0.000309	0.00562	CbGeAlD
Methysergide—SIGMAR1—heart—hypertension	0.000306	0.00556	CbGeAlD
Methysergide—HTR2B—heart—hypertension	0.000305	0.00554	CbGeAlD
Methysergide—SIGMAR1—smooth muscle tissue—hypertension	0.000303	0.00551	CbGeAlD
Methysergide—HTR1D—kidney—hypertension	0.000303	0.0055	CbGeAlD
Methysergide—HTR2B—smooth muscle tissue—hypertension	0.000303	0.0055	CbGeAlD
Methysergide—HTR7—brainstem—hypertension	0.000302	0.00549	CbGeAlD
Methysergide—SIGMAR1—decidua—hypertension	0.000297	0.0054	CbGeAlD
Methysergide—HTR2B—decidua—hypertension	0.000297	0.00539	CbGeAlD
Methysergide—HTR2B—cardiovascular system—hypertension	0.000288	0.00523	CbGeAlD
Methysergide—Methylergometrine—HTR2B—hypertension	0.000277	0.0624	CrCbGaD
Methysergide—SIGMAR1—cortex of kidney—hypertension	0.000275	0.005	CbGeAlD
Methysergide—HTR2B—cortex of kidney—hypertension	0.000274	0.00499	CbGeAlD
Methysergide—HTR2C—medulla oblongata—hypertension	0.000262	0.00476	CbGeAlD
Methysergide—SIGMAR1—cardiac atrium—hypertension	0.000261	0.00475	CbGeAlD
Methysergide—HTR7—heart—hypertension	0.000261	0.00475	CbGeAlD
Methysergide—HTR7—smooth muscle tissue—hypertension	0.000259	0.00471	CbGeAlD
Methysergide—HTR1A—cardiovascular system—hypertension	0.000258	0.00469	CbGeAlD
Methysergide—SIGMAR1—medulla oblongata—hypertension	0.000246	0.00448	CbGeAlD
Methysergide—HTR7—cardiovascular system—hypertension	0.000246	0.00448	CbGeAlD
Methysergide—HTR7—kidney—hypertension	0.000241	0.00438	CbGeAlD
Methysergide—Ergonovine—ADRA1A—hypertension	0.000238	0.0536	CrCbGaD
Methysergide—SIGMAR1—adrenal gland—hypertension	0.000228	0.00415	CbGeAlD
Methysergide—HTR2B—adrenal gland—hypertension	0.000228	0.00414	CbGeAlD
Methysergide—Lisuride—ADRA2B—hypertension	0.000225	0.0508	CrCbGaD
Methysergide—HTR1B—endocrine gland—hypertension	0.000219	0.00398	CbGeAlD
Methysergide—Ergotamine—ADRA2B—hypertension	0.000216	0.0488	CrCbGaD
Methysergide—HTR7—medulla oblongata—hypertension	0.000211	0.00383	CbGeAlD
Methysergide—Bromocriptine—ADRA2B—hypertension	0.000209	0.047	CrCbGaD
Methysergide—HTR1A—adrenal gland—hypertension	0.000204	0.00371	CbGeAlD
Methysergide—HTR1B—central nervous system—hypertension	0.000198	0.00359	CbGeAlD
Methysergide—HTR7—adrenal gland—hypertension	0.000195	0.00354	CbGeAlD
Methysergide—HTR1D—central nervous system—hypertension	0.000191	0.00348	CbGeAlD
Methysergide—Ergotamine—SLC6A2—hypertension	0.00019	0.0428	CrCbGaD
Methysergide—HTR2C—central nervous system—hypertension	0.000189	0.00344	CbGeAlD
Methysergide—HTR2A—brainstem—hypertension	0.000188	0.00342	CbGeAlD
Methysergide—Lisuride—HTR2B—hypertension	0.000186	0.0419	CrCbGaD
Methysergide—Ergotamine—HTR2B—hypertension	0.000178	0.0402	CrCbGaD
Methysergide—HTR2B—central nervous system—hypertension	0.000178	0.00323	CbGeAlD
Methysergide—HTR1A—endocrine gland—hypertension	0.000177	0.00322	CbGeAlD
Methysergide—Bromocriptine—HTR2B—hypertension	0.000172	0.0388	CrCbGaD
Methysergide—HTR7—endocrine gland—hypertension	0.000169	0.00307	CbGeAlD
Methysergide—HTR2A—heart—hypertension	0.000163	0.00296	CbGeAlD
Methysergide—HTR2A—smooth muscle tissue—hypertension	0.000162	0.00294	CbGeAlD
Methysergide—HTR1A—central nervous system—hypertension	0.000159	0.0029	CbGeAlD
Methysergide—HTR2A—cardiovascular system—hypertension	0.000154	0.00279	CbGeAlD
Methysergide—HTR7—central nervous system—hypertension	0.000152	0.00277	CbGeAlD
Methysergide—HTR2A—kidney—hypertension	0.00015	0.00273	CbGeAlD
Methysergide—Ergotamine—ADRA1A—hypertension	0.000134	0.0302	CrCbGaD
Methysergide—HTR2A—medulla oblongata—hypertension	0.000131	0.00239	CbGeAlD
Methysergide—Bromocriptine—ADRA1A—hypertension	0.000129	0.0291	CrCbGaD
Methysergide—HTR2A—adrenal gland—hypertension	0.000122	0.00221	CbGeAlD
Methysergide—Lisuride—HTR1B—hypertension	0.000111	0.0251	CrCbGaD
Methysergide—Lisuride—DRD3—hypertension	0.000108	0.0244	CrCbGaD
Methysergide—Ergotamine—HTR1B—hypertension	0.000107	0.0241	CrCbGaD
Methysergide—Bromocriptine—HTR7—hypertension	0.000107	0.024	CrCbGaD
Methysergide—HTR2A—endocrine gland—hypertension	0.000105	0.00192	CbGeAlD
Methysergide—Bromocriptine—HTR1B—hypertension	0.000103	0.0233	CrCbGaD
Methysergide—Bromocriptine—DRD3—hypertension	0.0001	0.0226	CrCbGaD
Methysergide—Lisuride—ADRA2A—hypertension	9.86e-05	0.0222	CrCbGaD
Methysergide—Lisuride—ADRB1—hypertension	9.85e-05	0.0222	CrCbGaD
Methysergide—HTR2A—central nervous system—hypertension	9.5e-05	0.00173	CbGeAlD
Methysergide—Ergotamine—ADRA2A—hypertension	9.48e-05	0.0214	CrCbGaD
Methysergide—Bromocriptine—ADRA2A—hypertension	9.14e-05	0.0206	CrCbGaD
Methysergide—Bromocriptine—ADRB1—hypertension	9.13e-05	0.0206	CrCbGaD
Methysergide—Methylergometrine—HTR2A—hypertension	8.62e-05	0.0194	CrCbGaD
Methysergide—Lisuride—DRD2—hypertension	7.48e-05	0.0169	CrCbGaD
Methysergide—Ergotamine—DRD2—hypertension	7.19e-05	0.0162	CrCbGaD
Methysergide—Bromocriptine—DRD2—hypertension	6.93e-05	0.0156	CrCbGaD
Methysergide—Lisuride—HTR2A—hypertension	5.78e-05	0.013	CrCbGaD
Methysergide—Ergotamine—HTR2A—hypertension	5.56e-05	0.0125	CrCbGaD
Methysergide—Bromocriptine—HTR2A—hypertension	5.36e-05	0.0121	CrCbGaD
Methysergide—Gastrointestinal disorder—Furosemide—hypertension	3.76e-05	0.000233	CcSEcCtD
Methysergide—Chest pain—Ramipril—hypertension	3.76e-05	0.000233	CcSEcCtD
Methysergide—Myalgia—Ramipril—hypertension	3.76e-05	0.000233	CcSEcCtD
Methysergide—Arthralgia—Ramipril—hypertension	3.76e-05	0.000233	CcSEcCtD
Methysergide—Dizziness—Fosinopril—hypertension	3.75e-05	0.000233	CcSEcCtD
Methysergide—Fatigue—Furosemide—hypertension	3.75e-05	0.000233	CcSEcCtD
Methysergide—Abdominal pain—Telmisartan—hypertension	3.75e-05	0.000233	CcSEcCtD
Methysergide—Body temperature increased—Telmisartan—hypertension	3.75e-05	0.000233	CcSEcCtD
Methysergide—Dyspnoea—Losartan—hypertension	3.74e-05	0.000232	CcSEcCtD
Methysergide—Somnolence—Losartan—hypertension	3.73e-05	0.000232	CcSEcCtD
Methysergide—Dizziness—Eplerenone—hypertension	3.73e-05	0.000232	CcSEcCtD
Methysergide—Vomiting—Indapamide—hypertension	3.73e-05	0.000232	CcSEcCtD
Methysergide—Vomiting—Diltiazem—hypertension	3.73e-05	0.000232	CcSEcCtD
Methysergide—Asthenia—Valsartan—hypertension	3.72e-05	0.000231	CcSEcCtD
Methysergide—Pain—Furosemide—hypertension	3.72e-05	0.000231	CcSEcCtD
Methysergide—Constipation—Furosemide—hypertension	3.72e-05	0.000231	CcSEcCtD
Methysergide—Gastrointestinal disorder—Betaxolol—hypertension	3.72e-05	0.000231	CcSEcCtD
Methysergide—Fatigue—Betaxolol—hypertension	3.71e-05	0.000231	CcSEcCtD
Methysergide—Ill-defined disorder—Lisinopril—hypertension	3.71e-05	0.000231	CcSEcCtD
Methysergide—Discomfort—Ramipril—hypertension	3.71e-05	0.00023	CcSEcCtD
Methysergide—Asthenia—Olmesartan—hypertension	3.71e-05	0.00023	CcSEcCtD
Methysergide—Dizziness—Nifedipine—hypertension	3.7e-05	0.00023	CcSEcCtD
Methysergide—Rash—Diltiazem—hypertension	3.7e-05	0.00023	CcSEcCtD
Methysergide—Rash—Indapamide—hypertension	3.7e-05	0.00023	CcSEcCtD
Methysergide—Dermatitis—Diltiazem—hypertension	3.7e-05	0.00023	CcSEcCtD
Methysergide—Dermatitis—Indapamide—hypertension	3.7e-05	0.00023	CcSEcCtD
Methysergide—Dyspepsia—Losartan—hypertension	3.7e-05	0.00023	CcSEcCtD
Methysergide—Vomiting—Carvedilol—hypertension	3.69e-05	0.000229	CcSEcCtD
Methysergide—Feeling abnormal—Perindopril—hypertension	3.69e-05	0.000229	CcSEcCtD
Methysergide—Dizziness—Verapamil—hypertension	3.69e-05	0.000229	CcSEcCtD
Methysergide—Constipation—Betaxolol—hypertension	3.68e-05	0.000229	CcSEcCtD
Methysergide—Pain—Betaxolol—hypertension	3.68e-05	0.000229	CcSEcCtD
Methysergide—Feeling abnormal—Irbesartan—hypertension	3.68e-05	0.000228	CcSEcCtD
Methysergide—Myalgia—Timolol—hypertension	3.67e-05	0.000228	CcSEcCtD
Methysergide—Arthralgia—Timolol—hypertension	3.67e-05	0.000228	CcSEcCtD
Methysergide—Chest pain—Timolol—hypertension	3.67e-05	0.000228	CcSEcCtD
Methysergide—Rash—Carvedilol—hypertension	3.66e-05	0.000228	CcSEcCtD
Methysergide—Gastrointestinal pain—Perindopril—hypertension	3.66e-05	0.000227	CcSEcCtD
Methysergide—Dermatitis—Carvedilol—hypertension	3.66e-05	0.000227	CcSEcCtD
Methysergide—Vomiting—Doxazosin—hypertension	3.65e-05	0.000227	CcSEcCtD
Methysergide—Gastrointestinal pain—Irbesartan—hypertension	3.65e-05	0.000227	CcSEcCtD
Methysergide—Feeling abnormal—Hydrochlorothiazide—hypertension	3.65e-05	0.000226	CcSEcCtD
Methysergide—Abdominal pain—Captopril—hypertension	3.64e-05	0.000226	CcSEcCtD
Methysergide—Body temperature increased—Captopril—hypertension	3.64e-05	0.000226	CcSEcCtD
Methysergide—Discomfort—Timolol—hypertension	3.63e-05	0.000225	CcSEcCtD
Methysergide—Rash—Doxazosin—hypertension	3.62e-05	0.000225	CcSEcCtD
Methysergide—Fatigue—Losartan—hypertension	3.62e-05	0.000225	CcSEcCtD
Methysergide—Dermatitis—Doxazosin—hypertension	3.62e-05	0.000225	CcSEcCtD
Methysergide—Gastrointestinal pain—Hydrochlorothiazide—hypertension	3.62e-05	0.000225	CcSEcCtD
Methysergide—Vomiting—Fosinopril—hypertension	3.61e-05	0.000224	CcSEcCtD
Methysergide—Malaise—Lisinopril—hypertension	3.61e-05	0.000224	CcSEcCtD
Methysergide—Nausea—Propranolol—hypertension	3.6e-05	0.000224	CcSEcCtD
Methysergide—Oedema—Ramipril—hypertension	3.6e-05	0.000224	CcSEcCtD
Methysergide—Constipation—Losartan—hypertension	3.59e-05	0.000223	CcSEcCtD
Methysergide—Pain—Losartan—hypertension	3.59e-05	0.000223	CcSEcCtD
Methysergide—Vomiting—Eplerenone—hypertension	3.59e-05	0.000223	CcSEcCtD
Methysergide—Feeling abnormal—Furosemide—hypertension	3.59e-05	0.000223	CcSEcCtD
Methysergide—Rash—Fosinopril—hypertension	3.58e-05	0.000222	CcSEcCtD
Methysergide—Dermatitis—Fosinopril—hypertension	3.58e-05	0.000222	CcSEcCtD
Methysergide—Vomiting—Nifedipine—hypertension	3.56e-05	0.000221	CcSEcCtD
Methysergide—Gastrointestinal pain—Furosemide—hypertension	3.56e-05	0.000221	CcSEcCtD
Methysergide—Rash—Eplerenone—hypertension	3.56e-05	0.000221	CcSEcCtD
Methysergide—Dermatitis—Eplerenone—hypertension	3.55e-05	0.000221	CcSEcCtD
Methysergide—Diarrhoea—Valsartan—hypertension	3.55e-05	0.000221	CcSEcCtD
Methysergide—Asthenia—Clonidine—hypertension	3.55e-05	0.00022	CcSEcCtD
Methysergide—Feeling abnormal—Betaxolol—hypertension	3.55e-05	0.00022	CcSEcCtD
Methysergide—Vomiting—Verapamil—hypertension	3.55e-05	0.00022	CcSEcCtD
Methysergide—Body temperature increased—Perindopril—hypertension	3.54e-05	0.00022	CcSEcCtD
Methysergide—Abdominal pain—Perindopril—hypertension	3.54e-05	0.00022	CcSEcCtD
Methysergide—Diarrhoea—Olmesartan—hypertension	3.53e-05	0.00022	CcSEcCtD
Methysergide—Rash—Nifedipine—hypertension	3.53e-05	0.000219	CcSEcCtD
Methysergide—Dermatitis—Nifedipine—hypertension	3.53e-05	0.000219	CcSEcCtD
Methysergide—Body temperature increased—Irbesartan—hypertension	3.53e-05	0.000219	CcSEcCtD
Methysergide—Abdominal pain—Irbesartan—hypertension	3.53e-05	0.000219	CcSEcCtD
Methysergide—Thrombocytopenia—Ramipril—hypertension	3.52e-05	0.000219	CcSEcCtD
Methysergide—Oedema—Timolol—hypertension	3.52e-05	0.000219	CcSEcCtD
Methysergide—Rash—Verapamil—hypertension	3.52e-05	0.000218	CcSEcCtD
Methysergide—Tachycardia—Ramipril—hypertension	3.51e-05	0.000218	CcSEcCtD
Methysergide—Dermatitis—Verapamil—hypertension	3.51e-05	0.000218	CcSEcCtD
Methysergide—Body temperature increased—Hydrochlorothiazide—hypertension	3.5e-05	0.000217	CcSEcCtD
Methysergide—Abdominal pain—Hydrochlorothiazide—hypertension	3.5e-05	0.000217	CcSEcCtD
Methysergide—Nausea—Diltiazem—hypertension	3.49e-05	0.000216	CcSEcCtD
Methysergide—Nausea—Indapamide—hypertension	3.49e-05	0.000216	CcSEcCtD
Methysergide—Asthenia—Trandolapril—hypertension	3.46e-05	0.000215	CcSEcCtD
Methysergide—Feeling abnormal—Losartan—hypertension	3.46e-05	0.000215	CcSEcCtD
Methysergide—Nausea—Carvedilol—hypertension	3.45e-05	0.000214	CcSEcCtD
Methysergide—Asthenia—Enalapril—hypertension	3.45e-05	0.000214	CcSEcCtD
Methysergide—Abdominal pain—Furosemide—hypertension	3.44e-05	0.000214	CcSEcCtD
Methysergide—Body temperature increased—Furosemide—hypertension	3.44e-05	0.000214	CcSEcCtD
Methysergide—Gastrointestinal pain—Losartan—hypertension	3.43e-05	0.000213	CcSEcCtD
Methysergide—Dizziness—Valsartan—hypertension	3.43e-05	0.000213	CcSEcCtD
Methysergide—Dizziness—Olmesartan—hypertension	3.42e-05	0.000212	CcSEcCtD
Methysergide—Nausea—Doxazosin—hypertension	3.41e-05	0.000212	CcSEcCtD
Methysergide—Chest pain—Lisinopril—hypertension	3.41e-05	0.000212	CcSEcCtD
Methysergide—Myalgia—Lisinopril—hypertension	3.41e-05	0.000212	CcSEcCtD
Methysergide—Arthralgia—Lisinopril—hypertension	3.41e-05	0.000212	CcSEcCtD
Methysergide—Body temperature increased—Betaxolol—hypertension	3.41e-05	0.000212	CcSEcCtD
Methysergide—Asthenia—Telmisartan—hypertension	3.4e-05	0.000211	CcSEcCtD
Methysergide—Diarrhoea—Clonidine—hypertension	3.39e-05	0.00021	CcSEcCtD
Methysergide—Nausea—Fosinopril—hypertension	3.37e-05	0.000209	CcSEcCtD
Methysergide—Discomfort—Lisinopril—hypertension	3.36e-05	0.000209	CcSEcCtD
Methysergide—Nausea—Eplerenone—hypertension	3.35e-05	0.000208	CcSEcCtD
Methysergide—Nausea—Nifedipine—hypertension	3.33e-05	0.000207	CcSEcCtD
Methysergide—Abdominal pain—Losartan—hypertension	3.32e-05	0.000206	CcSEcCtD
Methysergide—Body temperature increased—Losartan—hypertension	3.32e-05	0.000206	CcSEcCtD
Methysergide—Nausea—Verapamil—hypertension	3.31e-05	0.000206	CcSEcCtD
Methysergide—Asthenia—Captopril—hypertension	3.31e-05	0.000205	CcSEcCtD
Methysergide—Diarrhoea—Trandolapril—hypertension	3.3e-05	0.000205	CcSEcCtD
Methysergide—Vomiting—Valsartan—hypertension	3.3e-05	0.000205	CcSEcCtD
Methysergide—Diarrhoea—Enalapril—hypertension	3.29e-05	0.000204	CcSEcCtD
Methysergide—Vomiting—Olmesartan—hypertension	3.28e-05	0.000204	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Ramipril—hypertension	3.28e-05	0.000204	CcSEcCtD
Methysergide—Rash—Valsartan—hypertension	3.27e-05	0.000203	CcSEcCtD
Methysergide—Dizziness—Clonidine—hypertension	3.27e-05	0.000203	CcSEcCtD
Methysergide—Dermatitis—Valsartan—hypertension	3.27e-05	0.000203	CcSEcCtD
Methysergide—Oedema—Lisinopril—hypertension	3.26e-05	0.000203	CcSEcCtD
Methysergide—Rash—Olmesartan—hypertension	3.26e-05	0.000202	CcSEcCtD
Methysergide—Insomnia—Ramipril—hypertension	3.26e-05	0.000202	CcSEcCtD
Methysergide—Dermatitis—Olmesartan—hypertension	3.25e-05	0.000202	CcSEcCtD
Methysergide—Diarrhoea—Telmisartan—hypertension	3.24e-05	0.000201	CcSEcCtD
Methysergide—Paraesthesia—Ramipril—hypertension	3.23e-05	0.000201	CcSEcCtD
Methysergide—Asthenia—Perindopril—hypertension	3.21e-05	0.000199	CcSEcCtD
Methysergide—Dyspnoea—Ramipril—hypertension	3.21e-05	0.000199	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Timolol—hypertension	3.21e-05	0.000199	CcSEcCtD
Methysergide—Asthenia—Irbesartan—hypertension	3.2e-05	0.000199	CcSEcCtD
Methysergide—Somnolence—Ramipril—hypertension	3.2e-05	0.000199	CcSEcCtD
Methysergide—Thrombocytopenia—Lisinopril—hypertension	3.2e-05	0.000199	CcSEcCtD
Methysergide—Dizziness—Trandolapril—hypertension	3.19e-05	0.000198	CcSEcCtD
Methysergide—Tachycardia—Lisinopril—hypertension	3.19e-05	0.000198	CcSEcCtD
Methysergide—Insomnia—Timolol—hypertension	3.18e-05	0.000198	CcSEcCtD
Methysergide—Dizziness—Enalapril—hypertension	3.18e-05	0.000197	CcSEcCtD
Methysergide—Asthenia—Hydrochlorothiazide—hypertension	3.17e-05	0.000197	CcSEcCtD
Methysergide—Dyspepsia—Ramipril—hypertension	3.17e-05	0.000197	CcSEcCtD
Methysergide—Paraesthesia—Timolol—hypertension	3.16e-05	0.000196	CcSEcCtD
Methysergide—Diarrhoea—Captopril—hypertension	3.15e-05	0.000196	CcSEcCtD
Methysergide—Vomiting—Clonidine—hypertension	3.15e-05	0.000195	CcSEcCtD
Methysergide—Dyspnoea—Timolol—hypertension	3.14e-05	0.000195	CcSEcCtD
Methysergide—Dizziness—Telmisartan—hypertension	3.14e-05	0.000195	CcSEcCtD
Methysergide—Somnolence—Timolol—hypertension	3.13e-05	0.000194	CcSEcCtD
Methysergide—Asthenia—Furosemide—hypertension	3.12e-05	0.000194	CcSEcCtD
Methysergide—Rash—Clonidine—hypertension	3.12e-05	0.000194	CcSEcCtD
Methysergide—Dermatitis—Clonidine—hypertension	3.12e-05	0.000194	CcSEcCtD
Methysergide—Gastrointestinal disorder—Ramipril—hypertension	3.11e-05	0.000193	CcSEcCtD
Methysergide—Fatigue—Ramipril—hypertension	3.1e-05	0.000193	CcSEcCtD
Methysergide—Dyspepsia—Timolol—hypertension	3.1e-05	0.000192	CcSEcCtD
Methysergide—Asthenia—Betaxolol—hypertension	3.09e-05	0.000192	CcSEcCtD
Methysergide—Nausea—Valsartan—hypertension	3.08e-05	0.000191	CcSEcCtD
Methysergide—Constipation—Ramipril—hypertension	3.08e-05	0.000191	CcSEcCtD
Methysergide—Nausea—Olmesartan—hypertension	3.07e-05	0.000191	CcSEcCtD
Methysergide—Vomiting—Trandolapril—hypertension	3.07e-05	0.000191	CcSEcCtD
Methysergide—Diarrhoea—Perindopril—hypertension	3.06e-05	0.00019	CcSEcCtD
Methysergide—Vomiting—Enalapril—hypertension	3.06e-05	0.00019	CcSEcCtD
Methysergide—Diarrhoea—Irbesartan—hypertension	3.05e-05	0.00019	CcSEcCtD
Methysergide—Dizziness—Captopril—hypertension	3.05e-05	0.000189	CcSEcCtD
Methysergide—Rash—Trandolapril—hypertension	3.04e-05	0.000189	CcSEcCtD
Methysergide—Dermatitis—Trandolapril—hypertension	3.04e-05	0.000189	CcSEcCtD
Methysergide—Gastrointestinal disorder—Timolol—hypertension	3.04e-05	0.000189	CcSEcCtD
Methysergide—Fatigue—Timolol—hypertension	3.03e-05	0.000188	CcSEcCtD
Methysergide—Rash—Enalapril—hypertension	3.03e-05	0.000188	CcSEcCtD
Methysergide—Dermatitis—Enalapril—hypertension	3.03e-05	0.000188	CcSEcCtD
Methysergide—Diarrhoea—Hydrochlorothiazide—hypertension	3.03e-05	0.000188	CcSEcCtD
Methysergide—Vomiting—Telmisartan—hypertension	3.01e-05	0.000187	CcSEcCtD
Methysergide—Asthenia—Losartan—hypertension	3.01e-05	0.000187	CcSEcCtD
Methysergide—Pain—Timolol—hypertension	3.01e-05	0.000187	CcSEcCtD
Methysergide—Rash—Telmisartan—hypertension	2.99e-05	0.000186	CcSEcCtD
Methysergide—Dermatitis—Telmisartan—hypertension	2.99e-05	0.000185	CcSEcCtD
Methysergide—Diarrhoea—Furosemide—hypertension	2.98e-05	0.000185	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Lisinopril—hypertension	2.97e-05	0.000185	CcSEcCtD
Methysergide—Feeling abnormal—Ramipril—hypertension	2.97e-05	0.000184	CcSEcCtD
Methysergide—Dizziness—Perindopril—hypertension	2.96e-05	0.000184	CcSEcCtD
Methysergide—Insomnia—Lisinopril—hypertension	2.95e-05	0.000183	CcSEcCtD
Methysergide—Dizziness—Irbesartan—hypertension	2.95e-05	0.000183	CcSEcCtD
Methysergide—Diarrhoea—Betaxolol—hypertension	2.95e-05	0.000183	CcSEcCtD
Methysergide—Gastrointestinal pain—Ramipril—hypertension	2.94e-05	0.000183	CcSEcCtD
Methysergide—Nausea—Clonidine—hypertension	2.94e-05	0.000183	CcSEcCtD
Methysergide—Paraesthesia—Lisinopril—hypertension	2.93e-05	0.000182	CcSEcCtD
Methysergide—Vomiting—Captopril—hypertension	2.93e-05	0.000182	CcSEcCtD
Methysergide—Dizziness—Hydrochlorothiazide—hypertension	2.93e-05	0.000182	CcSEcCtD
Methysergide—Dyspnoea—Lisinopril—hypertension	2.91e-05	0.000181	CcSEcCtD
Methysergide—Rash—Captopril—hypertension	2.91e-05	0.000181	CcSEcCtD
Methysergide—Dermatitis—Captopril—hypertension	2.9e-05	0.00018	CcSEcCtD
Methysergide—Somnolence—Lisinopril—hypertension	2.9e-05	0.00018	CcSEcCtD
Methysergide—Feeling abnormal—Timolol—hypertension	2.9e-05	0.00018	CcSEcCtD
Methysergide—Gastrointestinal pain—Timolol—hypertension	2.88e-05	0.000179	CcSEcCtD
Methysergide—Dizziness—Furosemide—hypertension	2.88e-05	0.000179	CcSEcCtD
Methysergide—Dyspepsia—Lisinopril—hypertension	2.87e-05	0.000178	CcSEcCtD
Methysergide—Diarrhoea—Losartan—hypertension	2.87e-05	0.000178	CcSEcCtD
Methysergide—Nausea—Trandolapril—hypertension	2.87e-05	0.000178	CcSEcCtD
Methysergide—Nausea—Enalapril—hypertension	2.86e-05	0.000177	CcSEcCtD
Methysergide—Dizziness—Betaxolol—hypertension	2.85e-05	0.000177	CcSEcCtD
Methysergide—Vomiting—Perindopril—hypertension	2.85e-05	0.000177	CcSEcCtD
Methysergide—Abdominal pain—Ramipril—hypertension	2.85e-05	0.000177	CcSEcCtD
Methysergide—Body temperature increased—Ramipril—hypertension	2.85e-05	0.000177	CcSEcCtD
Methysergide—Vomiting—Irbesartan—hypertension	2.84e-05	0.000176	CcSEcCtD
Methysergide—Rash—Perindopril—hypertension	2.82e-05	0.000175	CcSEcCtD
Methysergide—Dermatitis—Perindopril—hypertension	2.82e-05	0.000175	CcSEcCtD
Methysergide—Gastrointestinal disorder—Lisinopril—hypertension	2.82e-05	0.000175	CcSEcCtD
Methysergide—Nausea—Telmisartan—hypertension	2.82e-05	0.000175	CcSEcCtD
Methysergide—Fatigue—Lisinopril—hypertension	2.81e-05	0.000175	CcSEcCtD
Methysergide—Vomiting—Hydrochlorothiazide—hypertension	2.81e-05	0.000175	CcSEcCtD
Methysergide—Rash—Irbesartan—hypertension	2.81e-05	0.000175	CcSEcCtD
Methysergide—Dermatitis—Irbesartan—hypertension	2.81e-05	0.000175	CcSEcCtD
Methysergide—Constipation—Lisinopril—hypertension	2.79e-05	0.000173	CcSEcCtD
Methysergide—Pain—Lisinopril—hypertension	2.79e-05	0.000173	CcSEcCtD
Methysergide—Rash—Hydrochlorothiazide—hypertension	2.79e-05	0.000173	CcSEcCtD
Methysergide—Dermatitis—Hydrochlorothiazide—hypertension	2.79e-05	0.000173	CcSEcCtD
Methysergide—Abdominal pain—Timolol—hypertension	2.78e-05	0.000173	CcSEcCtD
Methysergide—Body temperature increased—Timolol—hypertension	2.78e-05	0.000173	CcSEcCtD
Methysergide—Dizziness—Losartan—hypertension	2.78e-05	0.000172	CcSEcCtD
Methysergide—Vomiting—Furosemide—hypertension	2.77e-05	0.000172	CcSEcCtD
Methysergide—Rash—Furosemide—hypertension	2.74e-05	0.00017	CcSEcCtD
Methysergide—Dermatitis—Furosemide—hypertension	2.74e-05	0.00017	CcSEcCtD
Methysergide—Vomiting—Betaxolol—hypertension	2.74e-05	0.00017	CcSEcCtD
Methysergide—Nausea—Captopril—hypertension	2.74e-05	0.00017	CcSEcCtD
Methysergide—Rash—Betaxolol—hypertension	2.72e-05	0.000169	CcSEcCtD
Methysergide—Dermatitis—Betaxolol—hypertension	2.71e-05	0.000169	CcSEcCtD
Methysergide—Feeling abnormal—Lisinopril—hypertension	2.69e-05	0.000167	CcSEcCtD
Methysergide—Gastrointestinal pain—Lisinopril—hypertension	2.67e-05	0.000166	CcSEcCtD
Methysergide—Vomiting—Losartan—hypertension	2.67e-05	0.000166	CcSEcCtD
Methysergide—Nausea—Perindopril—hypertension	2.66e-05	0.000165	CcSEcCtD
Methysergide—Nausea—Irbesartan—hypertension	2.65e-05	0.000165	CcSEcCtD
Methysergide—Rash—Losartan—hypertension	2.65e-05	0.000164	CcSEcCtD
Methysergide—Dermatitis—Losartan—hypertension	2.64e-05	0.000164	CcSEcCtD
Methysergide—Nausea—Hydrochlorothiazide—hypertension	2.63e-05	0.000163	CcSEcCtD
Methysergide—Nausea—Furosemide—hypertension	2.58e-05	0.000161	CcSEcCtD
Methysergide—Asthenia—Ramipril—hypertension	2.58e-05	0.00016	CcSEcCtD
Methysergide—Abdominal pain—Lisinopril—hypertension	2.58e-05	0.00016	CcSEcCtD
Methysergide—Body temperature increased—Lisinopril—hypertension	2.58e-05	0.00016	CcSEcCtD
Methysergide—Nausea—Betaxolol—hypertension	2.56e-05	0.000159	CcSEcCtD
Methysergide—Asthenia—Timolol—hypertension	2.53e-05	0.000157	CcSEcCtD
Methysergide—Nausea—Losartan—hypertension	2.49e-05	0.000155	CcSEcCtD
Methysergide—Diarrhoea—Ramipril—hypertension	2.46e-05	0.000153	CcSEcCtD
Methysergide—Diarrhoea—Timolol—hypertension	2.41e-05	0.00015	CcSEcCtD
Methysergide—Dizziness—Ramipril—hypertension	2.38e-05	0.000148	CcSEcCtD
Methysergide—Asthenia—Lisinopril—hypertension	2.34e-05	0.000145	CcSEcCtD
Methysergide—Dizziness—Timolol—hypertension	2.33e-05	0.000145	CcSEcCtD
Methysergide—Vomiting—Ramipril—hypertension	2.29e-05	0.000142	CcSEcCtD
Methysergide—Rash—Ramipril—hypertension	2.27e-05	0.000141	CcSEcCtD
Methysergide—Dermatitis—Ramipril—hypertension	2.27e-05	0.000141	CcSEcCtD
Methysergide—Vomiting—Timolol—hypertension	2.24e-05	0.000139	CcSEcCtD
Methysergide—Diarrhoea—Lisinopril—hypertension	2.23e-05	0.000139	CcSEcCtD
Methysergide—Rash—Timolol—hypertension	2.22e-05	0.000138	CcSEcCtD
Methysergide—Dermatitis—Timolol—hypertension	2.22e-05	0.000138	CcSEcCtD
Methysergide—Dizziness—Lisinopril—hypertension	2.16e-05	0.000134	CcSEcCtD
Methysergide—Nausea—Ramipril—hypertension	2.14e-05	0.000133	CcSEcCtD
Methysergide—Nausea—Timolol—hypertension	2.09e-05	0.00013	CcSEcCtD
Methysergide—Vomiting—Lisinopril—hypertension	2.08e-05	0.000129	CcSEcCtD
Methysergide—Rash—Lisinopril—hypertension	2.06e-05	0.000128	CcSEcCtD
Methysergide—Dermatitis—Lisinopril—hypertension	2.06e-05	0.000128	CcSEcCtD
Methysergide—Nausea—Lisinopril—hypertension	1.94e-05	0.00012	CcSEcCtD
Methysergide—HTR2A—Signaling Pathways—ADCY5—hypertension	1.66e-06	1.48e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PIK3R1—hypertension	1.65e-06	1.47e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—NOS3—hypertension	1.65e-06	1.47e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CALM1—hypertension	1.65e-06	1.47e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PRKCG—hypertension	1.64e-06	1.47e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—LEP—hypertension	1.64e-06	1.46e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—APOE—hypertension	1.64e-06	1.46e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CALM1—hypertension	1.64e-06	1.46e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—FGF2—hypertension	1.64e-06	1.46e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ITGB3—hypertension	1.63e-06	1.46e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PRKCA—hypertension	1.63e-06	1.46e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—LEP—hypertension	1.63e-06	1.46e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—APOE—hypertension	1.63e-06	1.46e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—RHOA—hypertension	1.63e-06	1.46e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CAV1—hypertension	1.63e-06	1.45e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—APOA1—hypertension	1.62e-06	1.45e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—YWHAZ—hypertension	1.62e-06	1.45e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CAV1—hypertension	1.62e-06	1.44e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PIK3R1—hypertension	1.61e-06	1.44e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—NOS3—hypertension	1.61e-06	1.44e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—APOA1—hypertension	1.61e-06	1.44e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—MYC—hypertension	1.61e-06	1.44e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—KDR—hypertension	1.61e-06	1.43e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—TGFB1—hypertension	1.61e-06	1.43e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NGF—hypertension	1.6e-06	1.43e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SPP1—hypertension	1.6e-06	1.43e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—KDR—hypertension	1.6e-06	1.43e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—CXCL8—hypertension	1.59e-06	1.42e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—SERPINE1—hypertension	1.59e-06	1.42e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—EGFR—hypertension	1.58e-06	1.41e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—RELA—hypertension	1.56e-06	1.4e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—RELA—hypertension	1.56e-06	1.39e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CCR5—hypertension	1.56e-06	1.39e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PRKCD—hypertension	1.56e-06	1.39e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—RELA—hypertension	1.55e-06	1.38e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PRKCB—hypertension	1.55e-06	1.38e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—F2—hypertension	1.55e-06	1.38e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—FN1—hypertension	1.55e-06	1.38e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—F2—hypertension	1.54e-06	1.37e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—FN1—hypertension	1.54e-06	1.37e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PRKCB—hypertension	1.54e-06	1.37e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—FGF2—hypertension	1.54e-06	1.37e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MTOR—hypertension	1.53e-06	1.37e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—RHOA—hypertension	1.53e-06	1.37e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MTOR—hypertension	1.53e-06	1.37e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—C3—hypertension	1.52e-06	1.36e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MTOR—hypertension	1.52e-06	1.36e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—RELA—hypertension	1.52e-06	1.36e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PIK3R1—hypertension	1.52e-06	1.35e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—NOS3—hypertension	1.52e-06	1.35e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—NOTCH1—hypertension	1.51e-06	1.35e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—NOTCH1—hypertension	1.51e-06	1.34e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MTOR—hypertension	1.49e-06	1.33e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PDGFB—hypertension	1.48e-06	1.32e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—FGFR1—hypertension	1.47e-06	1.32e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CXCL8—hypertension	1.47e-06	1.31e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CXCL8—hypertension	1.47e-06	1.31e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CXCL8—hypertension	1.46e-06	1.3e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—HIF1A—hypertension	1.45e-06	1.3e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—AGT—hypertension	1.45e-06	1.29e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CXCL8—hypertension	1.43e-06	1.28e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—RELA—hypertension	1.43e-06	1.27e-05	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—AKT1—hypertension	1.42e-06	1.27e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CALM1—hypertension	1.42e-06	1.27e-05	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—AKT1—hypertension	1.42e-06	1.27e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—LEP—hypertension	1.42e-06	1.27e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—APOE—hypertension	1.42e-06	1.27e-05	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—AKT1—hypertension	1.41e-06	1.26e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—POMC—hypertension	1.41e-06	1.26e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CAV1—hypertension	1.4e-06	1.25e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—TP53—hypertension	1.4e-06	1.25e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—POMC—hypertension	1.4e-06	1.25e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—INS—hypertension	1.4e-06	1.25e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—APOA1—hypertension	1.4e-06	1.25e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—IL6—hypertension	1.4e-06	1.25e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MTOR—hypertension	1.4e-06	1.25e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—IL6—hypertension	1.4e-06	1.25e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—INS—hypertension	1.39e-06	1.24e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—IL6—hypertension	1.39e-06	1.24e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—KDR—hypertension	1.39e-06	1.24e-05	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—AKT1—hypertension	1.38e-06	1.23e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CCL2—hypertension	1.38e-06	1.23e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CCL2—hypertension	1.37e-06	1.22e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—IL6—hypertension	1.36e-06	1.22e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IGF1—hypertension	1.36e-06	1.21e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—AKT2—hypertension	1.35e-06	1.21e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—EGFR—hypertension	1.35e-06	1.2e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IGF1—hypertension	1.35e-06	1.2e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—AKT2—hypertension	1.35e-06	1.2e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CXCL8—hypertension	1.34e-06	1.2e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—EGFR—hypertension	1.34e-06	1.2e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—FN1—hypertension	1.34e-06	1.19e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—F2—hypertension	1.34e-06	1.19e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PRKCB—hypertension	1.34e-06	1.19e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MMP9—hypertension	1.33e-06	1.19e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MMP9—hypertension	1.33e-06	1.19e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CDKN1A—hypertension	1.33e-06	1.19e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CDKN1A—hypertension	1.33e-06	1.18e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—PTEN—hypertension	1.32e-06	1.18e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—TP53—hypertension	1.32e-06	1.18e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—PTEN—hypertension	1.32e-06	1.18e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MMP9—hypertension	1.32e-06	1.18e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CDKN1A—hypertension	1.32e-06	1.18e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PTEN—hypertension	1.31e-06	1.17e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NOTCH1—hypertension	1.31e-06	1.17e-05	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—AKT1—hypertension	1.3e-06	1.16e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MAPK8—hypertension	1.3e-06	1.16e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MMP9—hypertension	1.29e-06	1.16e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MAPK8—hypertension	1.29e-06	1.16e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—AKT1—hypertension	1.29e-06	1.15e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—AKT1—hypertension	1.29e-06	1.15e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CDKN1A—hypertension	1.29e-06	1.15e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—SERPINE1—hypertension	1.29e-06	1.15e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PTEN—hypertension	1.29e-06	1.15e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MAPK8—hypertension	1.29e-06	1.15e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IL6—hypertension	1.28e-06	1.15e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—AKT1—hypertension	1.28e-06	1.14e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—SERPINE1—hypertension	1.28e-06	1.14e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—IL6—hypertension	1.28e-06	1.14e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—EP300—hypertension	1.26e-06	1.13e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—EP300—hypertension	1.26e-06	1.13e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MAPK8—hypertension	1.26e-06	1.12e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—AKT1—hypertension	1.26e-06	1.12e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—EP300—hypertension	1.25e-06	1.12e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—FGF2—hypertension	1.25e-06	1.11e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—RHOA—hypertension	1.24e-06	1.11e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—FGF2—hypertension	1.24e-06	1.11e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—RHOA—hypertension	1.24e-06	1.1e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PIK3R1—hypertension	1.23e-06	1.1e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—NOS3—hypertension	1.23e-06	1.1e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—SRC—hypertension	1.23e-06	1.1e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—EP300—hypertension	1.23e-06	1.1e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—SRC—hypertension	1.23e-06	1.1e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PIK3R1—hypertension	1.22e-06	1.09e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—NOS3—hypertension	1.22e-06	1.09e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—SRC—hypertension	1.22e-06	1.09e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—POMC—hypertension	1.22e-06	1.09e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MMP9—hypertension	1.22e-06	1.09e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CDKN1A—hypertension	1.21e-06	1.08e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IL6—hypertension	1.21e-06	1.08e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—INS—hypertension	1.21e-06	1.08e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PTEN—hypertension	1.21e-06	1.08e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—VEGFA—hypertension	1.2e-06	1.07e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—VEGFA—hypertension	1.2e-06	1.07e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—SRC—hypertension	1.19e-06	1.07e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CCL2—hypertension	1.19e-06	1.06e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—VEGFA—hypertension	1.19e-06	1.06e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—AKT1—hypertension	1.18e-06	1.06e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MAPK8—hypertension	1.18e-06	1.06e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—AKT1—hypertension	1.18e-06	1.05e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IGF1—hypertension	1.17e-06	1.05e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—AKT2—hypertension	1.17e-06	1.04e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—EGFR—hypertension	1.17e-06	1.04e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—VEGFA—hypertension	1.16e-06	1.04e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—RELA—hypertension	1.16e-06	1.03e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—EP300—hypertension	1.15e-06	1.03e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—RELA—hypertension	1.15e-06	1.03e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MTOR—hypertension	1.13e-06	1.01e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MTOR—hypertension	1.13e-06	1.01e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—SRC—hypertension	1.12e-06	1e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—AKT1—hypertension	1.12e-06	9.98e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SERPINE1—hypertension	1.11e-06	9.93e-06	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MYC—hypertension	1.1e-06	9.83e-06	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MYC—hypertension	1.1e-06	9.82e-06	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TGFB1—hypertension	1.1e-06	9.8e-06	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TGFB1—hypertension	1.1e-06	9.79e-06	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MYC—hypertension	1.09e-06	9.75e-06	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—VEGFA—hypertension	1.09e-06	9.75e-06	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CXCL8—hypertension	1.09e-06	9.73e-06	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TGFB1—hypertension	1.09e-06	9.73e-06	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CXCL8—hypertension	1.08e-06	9.68e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—FGF2—hypertension	1.08e-06	9.61e-06	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—EGFR—hypertension	1.08e-06	9.61e-06	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—EGFR—hypertension	1.08e-06	9.6e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—RHOA—hypertension	1.07e-06	9.58e-06	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MYC—hypertension	1.07e-06	9.55e-06	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—EGFR—hypertension	1.07e-06	9.54e-06	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TGFB1—hypertension	1.07e-06	9.53e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PIK3R1—hypertension	1.06e-06	9.48e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NOS3—hypertension	1.06e-06	9.48e-06	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—AKT1—hypertension	1.05e-06	9.4e-06	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—AKT1—hypertension	1.05e-06	9.35e-06	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—EGFR—hypertension	1.05e-06	9.34e-06	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—IL6—hypertension	1.04e-06	9.26e-06	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—IL6—hypertension	1.03e-06	9.21e-06	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MYC—hypertension	1e-06	8.97e-06	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TGFB1—hypertension	1e-06	8.95e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—RELA—hypertension	1e-06	8.92e-06	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MMP9—hypertension	9.86e-07	8.8e-06	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—EGFR—hypertension	9.83e-07	8.77e-06	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CDKN1A—hypertension	9.83e-07	8.77e-06	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MMP9—hypertension	9.81e-07	8.76e-06	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PTEN—hypertension	9.8e-07	8.75e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MTOR—hypertension	9.8e-07	8.75e-06	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CDKN1A—hypertension	9.78e-07	8.73e-06	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PTEN—hypertension	9.75e-07	8.71e-06	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MAPK8—hypertension	9.59e-07	8.56e-06	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—AKT1—hypertension	9.56e-07	8.54e-06	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MAPK8—hypertension	9.54e-07	8.52e-06	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—AKT1—hypertension	9.52e-07	8.49e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CXCL8—hypertension	9.42e-07	8.41e-06	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—EP300—hypertension	9.35e-07	8.35e-06	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—EP300—hypertension	9.3e-07	8.3e-06	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—AKT1—hypertension	9.1e-07	8.12e-06	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—SRC—hypertension	9.09e-07	8.12e-06	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—SRC—hypertension	9.05e-07	8.08e-06	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TP53—hypertension	9.04e-07	8.07e-06	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TP53—hypertension	9.03e-07	8.06e-06	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TP53—hypertension	8.97e-07	8.01e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—IL6—hypertension	8.96e-07	8e-06	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—VEGFA—hypertension	8.86e-07	7.91e-06	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—VEGFA—hypertension	8.81e-07	7.86e-06	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TP53—hypertension	8.78e-07	7.84e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MMP9—hypertension	8.52e-07	7.61e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CDKN1A—hypertension	8.49e-07	7.58e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PTEN—hypertension	8.47e-07	7.56e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MAPK8—hypertension	8.29e-07	7.4e-06	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IL6—hypertension	8.27e-07	7.39e-06	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IL6—hypertension	8.26e-07	7.38e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—AKT1—hypertension	8.26e-07	7.38e-06	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TP53—hypertension	8.25e-07	7.37e-06	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IL6—hypertension	8.21e-07	7.33e-06	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MYC—hypertension	8.15e-07	7.27e-06	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TGFB1—hypertension	8.13e-07	7.26e-06	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MYC—hypertension	8.11e-07	7.24e-06	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TGFB1—hypertension	8.09e-07	7.22e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—EP300—hypertension	8.08e-07	7.21e-06	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IL6—hypertension	8.04e-07	7.18e-06	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—EGFR—hypertension	7.97e-07	7.11e-06	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—EGFR—hypertension	7.93e-07	7.08e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SRC—hypertension	7.85e-07	7.01e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—VEGFA—hypertension	7.65e-07	6.83e-06	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—AKT1—hypertension	7.63e-07	6.81e-06	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—AKT1—hypertension	7.62e-07	6.81e-06	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—AKT1—hypertension	7.58e-07	6.76e-06	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IL6—hypertension	7.55e-07	6.74e-06	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—AKT1—hypertension	7.42e-07	6.62e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MYC—hypertension	7.04e-07	6.28e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TGFB1—hypertension	7.02e-07	6.27e-06	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—AKT1—hypertension	6.97e-07	6.22e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—EGFR—hypertension	6.88e-07	6.15e-06	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TP53—hypertension	6.69e-07	5.97e-06	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TP53—hypertension	6.66e-07	5.94e-06	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IL6—hypertension	6.12e-07	5.47e-06	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IL6—hypertension	6.09e-07	5.44e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TP53—hypertension	5.78e-07	5.16e-06	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—AKT1—hypertension	5.65e-07	5.04e-06	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—AKT1—hypertension	5.62e-07	5.02e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IL6—hypertension	5.29e-07	4.72e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—AKT1—hypertension	4.88e-07	4.36e-06	CbGpPWpGaD
